NASDAQ:MTCR Archives - DRP Journal

Nasdaq Winners To Watch: GNPX, MTCR, CYTO, CREX, LPCN

November 22, 2021November 29, 2021 Pete Matthews Altamira Therapeutics Ltd (NASDAQ:CYTO), Creative Realities Inc. (NASDAQ:CREX), CREX, CREX news, CREX stock, CYTO, CYTO news, CYTO stock, Genprex Inc. (NASDAQ:GNPX), GNPX, GNPX news, GNPX stock, Lipocine Inc. (NASDAQ:LPCN), LPCN, LPCN news, LPCN stock, Metacrine Inc. (NASDAQ:MTCR), MTCR, MTCR news, MTCR stock, NASDAQ:CREX, NASDAQ:CYTO, NASDAQ:GNPX, NASDAQ:LPCN, NASDAQ:MTCR

Following were the key small-cap gainers on Friday. Keep an eye on these stocks. Genprex, Inc. (NASDAQ:GNPX) was one of

Nasdaq Winners To Watch: ONCS, MTCR, METX, AVGR, ZIOP

November 19, 2021November 29, 2021 Ash K AVGR, AVGR news, AVGR stock, Avinger Inc. (NASDAQ:AVGR), Metacrine Inc. (NASDAQ:MTCR), Meten Holdings Group Ltd. (NASDAQ:METX), METX, METX news, METX stock, MTCR, MTCR news, MTCR stock, NASDAQ:AVGR, NASDAQ:METX, NASDAQ:MTCR, NASDAQ:ONCS, NASDAQ:ZIOP, OncoSec Medical Incorporated (NASDAQ:ONCS), ONCS, ONCS news, ONCS stock, ZIOP, ZIOP news, ZIOP stock, Ziopharm Oncology Inc (NASDAQ:ZIOP)

Following were the key stock NASDAQ gainers on Thursday. Keep an eye on these stocks. OncoSec Medical Incorporated (NASDAQ:ONCS) was